Influence of Genetic Polymorphism of Donor on Tacrolimus Concentration in Liver Transplant

NCT03140462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2021-08-11

No results posted yet for this study

Summary

To study the influence of donor's ABCB1、CYP3A4、CYP3A5、POR genetic polymorphism on tacrolimus blood concentration in liver transplant recipients.

Conditions

  • Liver Transplantation

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Rey-Heng Hu · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-21
Primary Completion
2018-04-12
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03140462 on ClinicalTrials.gov